ArticleCurrent oncology (Toronto, Ont.)2023

Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective Study Based on a CRC Database.

Qiao Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.